Report Categories
View AllRecent Articles
View All
AUGO AuraMinerals posts sharp Q4 2025 EPS shortfall shares dip 122 percent on disappointing quarterly results
LENZ Therapeutics LENZ Stock Market Influencing Factors LENZ Therapeutics posts 171 EPS miss on wider quarterly loss
State Street SPDR Dow Jones Industrial Average ETF Trust DIA Posts 38 Weekly Gain Amid Geopolitical Optimism and Earnings Strength As Thematic Leveraged ETFs Deliver Record Outperformance
NTLA Intellia Therapeutics shares rise 832 percent after narrower Q4 2025 loss beats analyst expectations